In pathophysiological conditions, including hypertension, enhanced activation of the phospholipase C (PLC)–protein kinase C pathway may lead to inhibition of vasodilatory voltage-sensitive K+ channels (KV) (Ko et al., 2010) (Figure 2). Here, HSPG2 is linked to hypertensive disorder.